Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Perry

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Life Sciences|January 1, 1989
Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to miceR W Fuller, S K Hemrick-Luecke, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteineR W Fuller, S K Hemrick-Luecke, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin systemL Gong, R M Kostrzewa, R W Fuller, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatmentR Brus, R M Kostrzewa, K W Perry, et al.
Acta Neurobiologiae Experimentalis|January 1, 1996
Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT contentR M Kostrzewa, R Brus, K W Perry, et al.
Brain Research. Developmental Brain Research|December 17, 1993
Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of ratsL Gong, R M Kostrzewa, K W Perry, et al.
Brain Research. Developmental Brain Research|November 19, 1993
Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of ratsR M Kostrzewa, R Brus, K W Perry, et al.
Psychopharmacology|April 29, 1998
Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatumX M Li, K W Perry, D T Wong, et al.
Life Sciences|January 15, 1977
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsionsF B Bymaster, K W Perry, R W Fuller, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1974
6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in ratsR W Fuller, K W Perry, J C Baker, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Life Sciences|January 1, 1989
Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to miceR W Fuller, S K Hemrick-Luecke, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteineR W Fuller, S K Hemrick-Luecke, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin systemL Gong, R M Kostrzewa, R W Fuller, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatmentR Brus, R M Kostrzewa, K W Perry, et al.
Acta Neurobiologiae Experimentalis|January 1, 1996
Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT contentR M Kostrzewa, R Brus, K W Perry, et al.
Brain Research. Developmental Brain Research|December 17, 1993
Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of ratsL Gong, R M Kostrzewa, K W Perry, et al.
Brain Research. Developmental Brain Research|November 19, 1993
Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of ratsR M Kostrzewa, R Brus, K W Perry, et al.
Psychopharmacology|April 29, 1998
Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatumX M Li, K W Perry, D T Wong, et al.
Life Sciences|January 15, 1977
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsionsF B Bymaster, K W Perry, R W Fuller, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1974
6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in ratsR W Fuller, K W Perry, J C Baker, et al.
Pageof 12